Responses to the antagonistic analog of LH-RH (SB-75, cetrorelix) in patients with benign prostatic hyperplasia and prostatic cancer
- 1 February 1994
- journal article
- clinical trial
- Published by Wiley in The Prostate
- Vol. 24 (2) , 84-92
- https://doi.org/10.1002/pros.2990240206
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- New antagonists of LHRH II. Inhibition and potentiation of LHRH by closely related analoguesInternational Journal of Peptide and Protein Research, 1988
- Antide and related antagonists of luteinizing hormone release with long action and oral activity.Proceedings of the National Academy of Sciences, 1988
- Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects.Proceedings of the National Academy of Sciences, 1988
- Effectiveness of ultrasound in the preoperative evaluation of patients with prostatismThe Prostate, 1988
- Potent, long-acting luteinizing hormone releasing hormone antagonists containing new synthetic amino acids: N,N'-dialkyl-D-homoargininesJournal of Medicinal Chemistry, 1988
- New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitroJournal of Medicinal Chemistry, 1986
- Comparison of the Potential for Therapeutic Utilities with Gonadotropin-Releasing Hormone Agonists and AntagonistsEndocrine Reviews, 1986
- [Ac-D-NAL(2)1,4FD-Phe2,D-Trp3,D-Arg6]-LHRH, a potent antagonist of LHRH, produces transient edema and behavioral changes in ratsContraception, 1984
- Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.Proceedings of the National Academy of Sciences, 1982
- SUPPRESSION OF GONADOTROPHIN RELEASE IN MAN BY AN INHIBITORY ANALOGUE OF L.H.-RELEASING HORMONEThe Lancet, 1977